MX345230B - Metodos para diagnosticar patogenos de enfermedad infecciosa y su sensibilidad a farmacos. - Google Patents

Metodos para diagnosticar patogenos de enfermedad infecciosa y su sensibilidad a farmacos.

Info

Publication number
MX345230B
MX345230B MX2012009906A MX2012009906A MX345230B MX 345230 B MX345230 B MX 345230B MX 2012009906 A MX2012009906 A MX 2012009906A MX 2012009906 A MX2012009906 A MX 2012009906A MX 345230 B MX345230 B MX 345230B
Authority
MX
Mexico
Prior art keywords
methods
infectious disease
drug sensitivity
disease pathogens
diagnosing infectious
Prior art date
Application number
MX2012009906A
Other languages
English (en)
Other versions
MX2012009906A (es
Inventor
Hung Deborah
gomez James
Cosimi Lisa
Nicol Rob
Borowsky Mark
Barczak Amy
B Onderdonk Andrew
Original Assignee
The Broad Inst Inc *
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Broad Inst Inc * filed Critical The Broad Inst Inc *
Publication of MX2012009906A publication Critical patent/MX2012009906A/es
Publication of MX345230B publication Critical patent/MX345230B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/025—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/6895—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for plants, fungi or algae
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/5695—Mycobacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/35—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Mycobacteriaceae (F)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La presente invención se refiere en general a métodos para detectar, diagnosticar, y/o identificar patógenos, por ejemplo, patógenos de enfermedad infecciosa y determinar su sensibilidad a fármaco y métodos apropiados de tratamiento. Esta invención también ser refiere en general a métodos para verificar la infección por patógeno en sujetos individuales así como poblaciones más grandes de sujetos.
MX2012009906A 2010-02-24 2011-02-24 Metodos para diagnosticar patogenos de enfermedad infecciosa y su sensibilidad a farmacos. MX345230B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US30766910P 2010-02-24 2010-02-24
US32325210P 2010-04-12 2010-04-12
PCT/US2011/026092 WO2011106536A2 (en) 2010-02-24 2011-02-24 Methods of diagnosing infectious disease pathogens and their drug sensitivity

Publications (2)

Publication Number Publication Date
MX2012009906A MX2012009906A (es) 2015-09-28
MX345230B true MX345230B (es) 2017-01-20

Family

ID=44507562

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012009906A MX345230B (es) 2010-02-24 2011-02-24 Metodos para diagnosticar patogenos de enfermedad infecciosa y su sensibilidad a farmacos.

Country Status (10)

Country Link
US (5) US9885088B2 (es)
EP (2) EP2539467B1 (es)
JP (2) JP6138491B2 (es)
KR (1) KR20120133385A (es)
CN (2) CN103003446A (es)
AU (1) AU2011220736C1 (es)
CA (1) CA2791228C (es)
MX (1) MX345230B (es)
RU (1) RU2012140430A (es)
WO (1) WO2011106536A2 (es)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2539467B1 (en) 2010-02-24 2016-06-08 The Broad Institute, Inc. Methods of diagnosing infectious disease pathogens and their drug sensitivity
ITRM20100411A1 (it) * 2010-07-23 2012-01-24 Massimo Amicosante Uso di sequenze amminoacidiche da mycobacterium tuberculosis o dei loro corrispondenti acidi nucleici per la diagnosi e la prevenzione di infezione tubercolare, relativo kit diagnostico e vaccino.
US20140349320A1 (en) * 2011-12-15 2014-11-27 The Trustees Of The University Of Pennsylvania Using Adaptive Immunity to Detect Drug Resistance
GB201220662D0 (en) * 2012-11-16 2013-01-02 ALERE TECHNOLOGIES GmbH Assays
WO2014143158A1 (en) 2013-03-13 2014-09-18 The Broad Institute, Inc. Compositions and methods for labeling of agents
CN105473740B (zh) * 2013-07-03 2021-04-09 克维拉公司 靶向抗生素敏感性测试的方法
AU2015273443B2 (en) 2014-06-13 2021-03-04 Q-Linea Ab Method for detecting and characterising a microorganism
CN106715768B (zh) * 2014-07-30 2020-06-16 哈佛学院院长及董事 用于测定核酸的***和方法
EP3215631A4 (en) * 2014-11-05 2018-08-08 California Institute of Technology Microfluidic measurements of the response of an organism to a drug
KR101649851B1 (ko) * 2014-12-30 2016-08-30 주식회사 인트론바이오테크놀로지 신규한 시가독소생산 F18형 대장균 박테리오파지 Ｅｓｃ-ＣＯＰ-1 및 이의 시가독소생산 F18형 대장균 증식 억제 용도
GB201507026D0 (en) 2015-04-24 2015-06-10 Linea Ab Q Medical sample transportation container
WO2017011819A1 (en) * 2015-07-15 2017-01-19 Northeastern University Microdroplet based bioassay platform
US11332783B2 (en) 2015-08-28 2022-05-17 The Broad Institute, Inc. Sample analysis, presence determination of a target sequence
WO2017139715A1 (en) * 2016-02-11 2017-08-17 The Translational Genomics Research Institute Systems and methods for the detection of infectious diseases
GB2554767A (en) 2016-04-21 2018-04-11 Q Linea Ab Detecting and characterising a microorganism
WO2018058078A1 (en) 2016-09-23 2018-03-29 California Institute Of Technology Digital quantification of dna replication and/or chromosome segregation based determination of antimicrobial susceptibility
CA3049961A1 (en) 2016-12-09 2018-06-14 The Broad Institute, Inc. Crispr effector system based diagnostics
CN106636410A (zh) * 2016-12-28 2017-05-10 山东省农业科学院畜牧兽医研究所 环介导等温扩增多重耐药基因oqxAB的检测引物、检测试剂盒及检测方法
KR101750972B1 (ko) * 2017-02-21 2017-06-27 신영수 약물의 면역 반응 유도능 평가용 조성물
EP4166677A1 (en) * 2017-03-01 2023-04-19 Specific Technologies, LLC Detection of drug resistance of microorganisms
US11174515B2 (en) 2017-03-15 2021-11-16 The Broad Institute, Inc. CRISPR effector system based diagnostics
US11104937B2 (en) 2017-03-15 2021-08-31 The Broad Institute, Inc. CRISPR effector system based diagnostics
WO2018170340A1 (en) 2017-03-15 2018-09-20 The Broad Institute, Inc. Crispr effector system based diagnostics for virus detection
US11618928B2 (en) 2017-04-12 2023-04-04 The Broad Institute, Inc. CRISPR effector system based diagnostics for malaria detection
US11131673B2 (en) 2017-04-27 2021-09-28 Northeastern University Live single-cell bioassay in microdroplets
WO2018218150A1 (en) 2017-05-26 2018-11-29 President And Fellows Of Harvard College Systems and methods for high-throughput image-based screening
WO2019075264A1 (en) 2017-10-11 2019-04-18 California Institute Of Technology ANTIBIOSENSITIVITY OF MICROORGANISMS AND COMPOSITIONS, METHODS AND ASSOCIATED SYSTEMS
CN108165564B (zh) * 2017-12-01 2021-06-08 北京蛋白质组研究中心 结核分枝杆菌H37Rv编码基因及其应用
BR112020015093A2 (pt) 2018-01-29 2020-12-08 The Broad Institute, Inc. Diagnóstico baseado no sistema de efetor crispr
EP3844296A4 (en) * 2018-08-27 2022-06-15 The Broad Institute, Inc. COMPOSITIONS AND METHODS FOR DETECTING ANTIBIOTIC-SENSITIVE MRNA EXPRESSION SIGNATURES AND USES THEREOF
WO2020061643A1 (en) * 2018-09-27 2020-04-02 Garvan Institute Of Medical Research Expression profiling
EP3861129A4 (en) * 2018-10-02 2022-07-20 BioFire Diagnostics, LLC BACTERIAL RESPONSE
US20210396756A1 (en) 2018-10-03 2021-12-23 The Broad Institute, Inc. Crispr effector system based diagnostics for hemorrhagic fever detection
CN109557296B (zh) * 2018-11-22 2022-05-20 珠海澳加动力生物科技有限公司 一种循环检测肿瘤细胞药物敏感性的方法
CN109671467B (zh) * 2018-12-12 2023-03-24 中国人民解放军军事科学院军事医学研究院 一种病原体感染损伤机理解析方法及装置
WO2020160044A1 (en) 2019-01-28 2020-08-06 The Broad Institute, Inc. In-situ spatial transcriptomics
WO2020186223A1 (en) 2019-03-14 2020-09-17 The Broad Institute, Inc. Sherlock assays for tick-borne diseases
CN110499353B (zh) * 2019-08-09 2023-11-07 佛山市第四人民医院(佛山市结核病防治所) 一种用于结核耐药诊断的微生物标志物及其应用
CN114867871A (zh) * 2019-12-27 2022-08-05 豪夫迈·罗氏有限公司 用于检测耐甲氧西林金黄色葡萄球菌的组合物和方法
IN202041055641A (es) * 2020-12-21 2021-11-19

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6300058B1 (en) 1992-01-29 2001-10-09 Hitachi Chemical Research Center, Inc. Method for measuring messenger RNA
US5637684A (en) 1994-02-23 1997-06-10 Isis Pharmaceuticals, Inc. Phosphoramidate and phosphorothioamidate oligomeric compounds
US20080113342A1 (en) * 1998-11-16 2008-05-15 Monsanto Technology Llc Plant Genome Sequence and Uses Thereof
JP2001103981A (ja) 1999-08-03 2001-04-17 Nisshinbo Ind Inc 結核菌診断キット
AU7606100A (en) * 1999-09-24 2001-04-24 Pharmacia & Upjohn Company Gene expression profiles
EP1261716A2 (en) * 1999-11-16 2002-12-04 Apollo Biotechnology, Inc. Method for rapid and accurate identification of microorganisms
WO2002077183A2 (en) * 2001-03-21 2002-10-03 Elitra Pharmaceuticals, Inc. Identification of essential genes in microorganisms
KR100454585B1 (ko) 2001-10-09 2004-11-02 주식회사 에스제이하이테크 마이코박테리아의 균주 감별, 결핵균의 스트레인 감별과항생제 내성을 검출하기 위한 프로브를 포함하는마이크로어레이와 이를 이용한 검출 방법 및 진단 키트
CN1580283A (zh) 2003-08-13 2005-02-16 清华大学 一种检测核酸分子的方法
US7611834B2 (en) 2005-09-30 2009-11-03 Sandia Corporation Methods and devices for protein assays
AU2008237018B2 (en) 2007-04-10 2014-04-03 Nanostring Technologies, Inc. Methods and computer systems for identifying target-specific sequences for use in nanoreporters
JP2009017836A (ja) * 2007-07-13 2009-01-29 Gifu Univ 生菌の遺伝子検査方法
AU2008282742A1 (en) 2007-08-01 2009-02-05 Medivation Neurology, Inc. Methods and compositions for treating schizophrenia using antipsychotic combination therapy
US20090082552A1 (en) 2007-09-26 2009-03-26 Magdalena Bynum Microfluidic protein assay
US20100222289A1 (en) * 2007-10-22 2010-09-02 Cfs Research Llc Methods for diagnosis and treatment of chronic fatigue syndrome
US20120165246A1 (en) * 2009-02-26 2012-06-28 Tyrian Diagnostics Limited Method of Diagnosis of Infection by Mycobacteria and Reagents Therefor
EP2539467B1 (en) 2010-02-24 2016-06-08 The Broad Institute, Inc. Methods of diagnosing infectious disease pathogens and their drug sensitivity

Also Published As

Publication number Publication date
KR20120133385A (ko) 2012-12-10
WO2011106536A3 (en) 2012-02-02
CN103003446A (zh) 2013-03-27
MX2012009906A (es) 2015-09-28
EP2539467A4 (en) 2013-09-25
US20130190196A1 (en) 2013-07-25
RU2012140430A (ru) 2014-03-27
WO2011106536A2 (en) 2011-09-01
AU2011220736B2 (en) 2014-08-14
EP2816123A1 (en) 2014-12-24
US20150203900A1 (en) 2015-07-23
WO2011106536A9 (en) 2012-03-15
AU2011220736C1 (en) 2014-12-18
US20210062246A1 (en) 2021-03-04
JP6138491B2 (ja) 2017-05-31
US10982291B2 (en) 2021-04-20
CA2791228C (en) 2020-07-07
EP2816123B1 (en) 2018-09-12
EP2539467B1 (en) 2016-06-08
EP2539467A2 (en) 2013-01-02
US20190119728A1 (en) 2019-04-25
CA2791228A1 (en) 2011-09-01
US20220251631A1 (en) 2022-08-11
AU2011220736A1 (en) 2012-09-13
JP2016073282A (ja) 2016-05-12
JP2013520206A (ja) 2013-06-06
CN104212890A (zh) 2014-12-17
US9885088B2 (en) 2018-02-06

Similar Documents

Publication Publication Date Title
MX345230B (es) Metodos para diagnosticar patogenos de enfermedad infecciosa y su sensibilidad a farmacos.
WO2012054589A3 (en) Conduit-containing devices and methods for analyte processing and detection
WO2012054638A3 (en) Nmr systems and methods for the detection of analytes
MX343327B (es) Ensayos para detectar autoanticuerpos contra farmacos anti-tnfa.
WO2012142301A3 (en) Methods of determining a treatment protocol for and/or a prognosis of a patients recovery from a brain injury
BR112013010023A2 (pt) algoritimo aperfeiçoado para a detecção de diabetes
MX358517B (es) Métodos para determinar eficacia de fármacos usando proteínas asociadas a cereblon.
WO2011135459A3 (en) Methods and devices for predicting treatment efficacy
NZ708197A (en) Systems and methods for predicting the outcome of a state of a subject
EP2596132A4 (en) METHOD FOR DETECTING SIGNS FOR ILLNESS OR SUFFERING IN BODY FLUIDS
MX2010014228A (es) Metodos y productos de diagnostico del p/gf-1 acompañante.
MX2013000675A (es) Metodo para identificar a un paciente con incrementada probabilidad de responder a una terapia anticancer.
WO2014015149A3 (en) Use of microvesicles in diagnosis, prognosis, and treatment of medical diseases and conditions
DK2928923T3 (da) Antistoffer mod dendritisk celle-antigen 2 fra blod og anvendelser deraf
IL210952A0 (en) Methods and compositions for detection of a pathogen, disease, medical condition, or biomarker thereof
MX2013015409A (es) Diagnostico de la enfermedad de alzheimer.
WO2012142300A3 (en) Methods of determining a treatment protocol for and/or a prognosis of a patient's recovery from a brain injury resulting from a hypoxic event
MX2017006242A (es) Determinacion de niveles de glicosaminoglicanos mediante espectrometria de masas.
WO2012065117A3 (en) Oral cancer point of care diagnostics
GB2515713A (en) Methods, packaging and apparatus for collection of biological samples
WO2011112805A3 (en) Compositions and methods for screening for lyme disease
WO2012109258A3 (en) Compositions adn methods for monitoring oxalate
EP3153861A3 (en) Biomarkers for predicting response to a cancer vaccine
GB2500129A (en) Detection and/or diagnosis of mite infections in sheep
WO2014087241A3 (en) Methods of detecting biofilms from the palmitoylation of lipopolysaccharides

Legal Events

Date Code Title Description
FG Grant or registration